US pharma firms Gilead and Mylan deliver 50,000 vials of Amphotericin B to India :
India received around 50,000 vials of Amphotericin-B from US-based Gilead Sciences and Mylan on 28 May 2021. This drug is used for treating patients with black fungus. The Union Minister of State for Chemicals and Fertilizers has expressed his gratitude for this gesture. 1
Black Fungus or Mucormycosis is a fungal infection that is causing chaos in India, especially in COVID-19 patients. Patients who have been treated using large doses of steroids are shown to be highly susceptible to Black Fungus.
Owing to the rapid surge in the number of cases pan India, over 20 states have declared it as a notifiable disease under the Epidemic Diseases Act, 1897. This includes states like Delhi, Madhya Pradesh, Rajasthan, Uttarakhand, Tamil Nadu, and Bihar.
Amidst the rising cases, the Prime Minister issued instructions to procure the anti-fungal drug on a war footing. All concerned officials were asked to get the drug from anywhere it is available in the world.
Gilead delivers Amphotericin B.
- Is Big Data Analytics revamping the Pharmaceutical Industry?
- Pharma News August 2021
- All you need to know about popular Pantoprazole Brands
- Monthly Update- pharma News July 2021
- Proton Pump Inhibitors: Pharmacokinetic Properties
- Moderna collaborates with Thermo Fischer Scientific
- Bamlanivimab and Etesevimab: EUA in India
- JB Chemicals launches NOSMOK nicotine lozenges
- Pharmacology Notes
- 2-DG: anti-COVID-19 by the INMAS